Inman Pharmacy owner Mike Reppucci says reimbursements on GLP-1s often come in below the cost to acquire the drugs. (Nicole DeFeudis for Endpoints News)

Lo­cal phar­ma­cies say they're strug­gling to af­ford GLP-1s

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

Har­ry Webb has seen a flur­ry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.